Related Experiment Video
Updated: Jun 26, 2026

05:51
An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons
Published on: May 23, 2019
6.5K
GV1001 reduces pathological 4R tau and functional deficits in models relevant to progressive supranuclear palsy
Kyu-Beom Jang1, Dong Min Kang2,3, Myung-Hoon Lee1
1R&D Center, GemVax & KAEL, 117, Unjung-ro, Seongnam-si, Gyeonggi-do, 13461, Republic of Korea.
Scientific Reports
|March 9, 2026
Summary
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

